Subscribe to:
AIDSmeds & POZ newsletters
POZ magazine
Personals Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Hormonally Challenged
Montaner: Treat HIV to Help Curb Infection Spread
Ready to Quit? The Risks and Rewards of a Potent Smoking-Cessation Drug
Zinc Fingers to the Fore
Deep Vein Clotting Risk Higher in HIV
Experimental HIV Drug Hits Snag
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Herpes Simplex Virus
Syphilis & Neurosyphilis
Shingles
The HIV Life Cycle
Human Papilloma Virus (HPV)
Treatments for Opportunistic Infections (OIs)
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

May 7, 2008

Antiretrovirals Vital in Treating Cancer

Antireteroviral (ARV) treatment and chemotherapy, more than any other factors, substantially increase the odds that a person with Kaposi’s sarcoma (KS)—a type of skin cancer common with HIV—will see their cancer improve and even go away, say the authors of a study published in the May 11 issue of AIDS.

Huong Nguyen, PhD, RN, from the Department of Epidemiology at the University of Washington in Seattle, and her colleagues examined the medical records of people living with HIV who were being treated at the university’s HIV clinic. They identified 64 people who were confirmed to have KS. All were men, and 31 percent had a more serious stage of KS, which when aggressive spreads to the lungs and intestines or causes ulcers and swelling.

Nguyen’s team found that approximately half of the people diagnosed with KS had complete resolution—meaning that all KS lesions disappeared—within 36 months.
When Nguyen's team looked only at improvement of KS, they found that people taking ARV treatment were four times as likely to see improvement as people not taking ARV treatment—regardless of their viral load or CD4 counts—and that people using chemotherapy were more than five times as likely to see improvement as people not using chemotherapy. When the team looked only at resolution of KS, however, only the use of ARV treatment was associated with it, again regardless of CD4 count or viral load. People taking ARV treatment were six times as likely to have resolution of their KS as people not taking ARV treatment.

Search: Kaposi's sarcoma, chemotherapy, cancer, Huong Nguyen, University of Washington


Scroll down to comment on this story.

emailrssprint

Name:

(2-50 characters)

Email:

(will not show)

City:

(optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

comments 1 - 1 (of 1 total)    

cj, atlanta, 2008-05-07 20:20:15
This is great news. I am battling KS and currently undergoing chemo treatments. I have just started ARVs this month. I have seen great improvement since being chemo

comments 1 - 1 (of 1 total)    


[Go to top]

Get Started
Get Answers
I'm HIV positive. What's next?
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Conference Coverage

CROI 2008
Boston, MA
February 3-8, 2008


2007 National Prevention Conference
Atlanta
December 2-7, 2007


11th European AIDS Conference / EACS
Madrid, Spain
October 24-27, 2007


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertise/contact us]

© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy